Literature DB >> 11100284

Post-transplant lymphoproliferative disorder after autologous peripheral stem cell transplantation in a pediatric patient.

M A Lones1, I Kirov, J W Said, I P Shintaku, S Neudorf.   

Abstract

Post-transplant lymphoproliferative disorder (PTLD) is a complication of allogeneic bone marrow transplantation (BMT). Rare cases of PTLD after autologous BMT have been reported only in adults. This case report is the first to describe PTLD in a pediatric patient after autologous peripheral stem cell transplantation (PSCT). This 2-year-old male with stage IV neuroblastoma underwent autologous PSCT. The post-PSCT course was complicated by fever with hematochezia and a lung mass. On day 94 post PSCT, colonoscopy revealed an ulcer due to a PTLD, monomorphic type, B cell phenotype, associated with Epstein-Barr virus. Fine needle aspiration identified the lung mass as neuroblastoma. PTLD can occur in pediatric autologous PSCT recipients, and may occur more frequently in autologous grafts manipulated by T cell depletion or CD34+ cell selection.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11100284     DOI: 10.1038/sj.bmt.1702593

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  8 in total

Review 1.  Strategies to prevent EBV reactivation and posttransplant lymphoproliferative disorders (PTLD) after allogeneic stem cell transplantation in high-risk patients.

Authors:  Nishitha Reddy; Katayoun Rezvani; A John Barrett; Bipin N Savani
Journal:  Biol Blood Marrow Transplant       Date:  2010-08-21       Impact factor: 5.742

2.  Epstein-Barr virus-associated lymphoproliferative disorder developed following autologous peripheral blood stem cell transplantation for relapsing Hodgkin's lymphoma.

Authors:  Sakura Izumiya; Mitsuaki Ishida; Keiko Hodohara; Takashi Yoshida; Hidetoshi Okabe
Journal:  Oncol Lett       Date:  2012-04-03       Impact factor: 2.967

Review 3.  Posttransplant lymphoproliferative disease: pathogenesis, monitoring, and therapy.

Authors:  Richard F Ambinder
Journal:  Curr Oncol Rep       Date:  2003-09       Impact factor: 5.075

Review 4.  The central nervous system complications of bone marrow transplantation in children.

Authors:  Shoko Yoshida; Katsumi Hayakawa; Akira Yamamoto; Hiroshi Kuroda; Shinsaku Imashuku
Journal:  Eur Radiol       Date:  2008-05-20       Impact factor: 5.315

5.  Endobronchial Epstein-Barr Virus Associated Post-transplant Lymphoproliferative Disorder in Hematopoietic Stem Cell Transplantation.

Authors:  S Feuillet; V Meignin; J Brière; P Brice; V Rocha; G Socié; A Tazi; A Bergeron
Journal:  Clin Med Case Rep       Date:  2009-02-03

6.  A pilot study of tandem high-dose chemotherapy with stem cell rescue as consolidation for high-risk neuroblastoma: Children's Oncology Group study ANBL00P1.

Authors:  A E Seif; A Naranjo; D L Baker; N J Bunin; M Kletzel; C S Kretschmar; J M Maris; P W McGrady; D von Allmen; S L Cohn; W B London; J R Park; L R Diller; S A Grupp
Journal:  Bone Marrow Transplant       Date:  2013-01-21       Impact factor: 5.483

Review 7.  Gastrointestinal complications following hematopoietic stem cell transplantation in children.

Authors:  Ji-Hye Lee; Gye-Yeon Lim; Soo Ah Im; Nak-Gyun Chung; Seung-Tae Hahn
Journal:  Korean J Radiol       Date:  2008 Sep-Oct       Impact factor: 3.500

8.  An unexpectedly high incidence of Epstein-Barr virus lymphoproliferative disease after CD34+ selected autologous peripheral blood stem cell transplant in neuroblastoma.

Authors:  J L Powell; N J Bunin; C Callahan; R Aplenc; G Griffin; S A Grupp
Journal:  Bone Marrow Transplant       Date:  2004-03       Impact factor: 5.483

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.